Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Entrada Therapeutics (TRDA) Prepaid Assets: 2022-2025

Historic Prepaid Assets for Entrada Therapeutics (TRDA) over the last 4 years, with Sep 2025 value amounting to $10.2 million.

  • Entrada Therapeutics' Prepaid Assets fell 23.64% to $10.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.2 million, marking a year-over-year decrease of 23.64%. This contributed to the annual value of $16.4 million for FY2024, which is 37.21% up from last year.
  • As of Q3 2025, Entrada Therapeutics' Prepaid Assets stood at $10.2 million, which was down 26.74% from $14.0 million recorded in Q2 2025.
  • Entrada Therapeutics' Prepaid Assets' 5-year high stood at $24.4 million during Q3 2023, with a 5-year trough of $8.8 million in Q1 2022.
  • In the last 3 years, Entrada Therapeutics' Prepaid Assets had a median value of $13.4 million in 2024 and averaged $14.2 million.
  • Its Prepaid Assets has fluctuated over the past 5 years, first crashed by 45.22% in 2024, then soared by 101.58% in 2025.
  • Entrada Therapeutics' Prepaid Assets (Quarterly) stood at $21.2 million in 2022, then slumped by 43.66% to $11.9 million in 2023, then soared by 37.21% to $16.4 million in 2024, then decreased by 23.64% to $10.2 million in 2025.
  • Its Prepaid Assets stands at $10.2 million for Q3 2025, versus $14.0 million for Q2 2025 and $18.6 million for Q1 2025.